£51.61

It has never been this cheap. We have no record of a lower price.

£52 today · cheaper than every other day in the last 3 months

CRC Press Benefit-Risk Assessment in Pharmaceutical Research and Development (Chapman & Hall/CRC Biostatistics Series)

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 26 days · 26 data points (no recent data)

Historical
Generating forecast…
£51.61 £49.03 £50.06 £51.09 £52.13 £53.16 £54.19 22 August 2026 28 August 2026 03 September 2026 09 September 2026 16 September 2026
View at Amazon ↗

Price data last checked 65 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 26 days • 1 price levels

Days at Price
26 days 0 7 13 20 26 £52 Days at Price

Price Analysis

Most common price: £52 (26 days, 100.0%)

Price range: £52 - £52

Price levels: 1 different prices over 26 days

Description

Many practitioners in the pharmaceutical industry are still largely unfamiliar with benefit-risk assessment, despite its growing prominence in drug development and commercialization. Helping to alleviate this knowledge gap, Benefit-Risk Assessment in Pharmaceutical Research and Development provides a succinct overview of the key considerations relevant to benefit-risk assessment across the pharmaceutical R&D spectrum, from early clinical development to late-stage development to regulatory review to post-launch assessment. The book first presents interpretations of benefit and risk in the context of a molecule moving from preclinical evaluation into its early testing in humans. It next considers benefit and risk characterization and assessment during a molecule’s journey from its clinical evaluation in humans through its submission to regulators for marketing approval. Throughout these sections, the book offers insight into the role of benefit-risk assessment in heightening understanding among key stakeholders by shaping questions and guiding discussions among scientists, physicians, developers, and regulatory agencies. The book also focuses on a molecule’s entry into the marketplace as a drug available for consumption by people. It explores the role of benefit-risk assessment as the relevance of carefully collected clinical efficacy and safety metrics fades in the wake of real-world use and evidence of effectiveness and safety. Bringing together the expertise of 15 contributors from academia and the industry, this book offers an easy-to-read guide to the various facets of benefit-risk assessment in the major stages of pharmaceutical R&D. Suitable for those in both technical and managerial roles, it enables readers to communicate more effectively across their development chain as well as rationally and thoughtfully embed benefit-risk assessment into their R&D processes.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
30 June 2020
Listed Since
29 May 2020

Barcode

No barcode data available

Similar Products You Might Like

Benefit-Risk Assessment Methods in Medical Product Development: Bridging Qualitative and Quantitative Assessments (Chapman & Hall/CRC Biostatistics Series)
90% match

Benefit-Risk Assessment Methods in Medical Product Development: Bridging Qualitative and Quantitative Assessments (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£103.32 16 Sep 2026
Biomarkers in Drug Development: Statistical Methods and Applications (Chapman & Hall/CRC Biostatistics Series)
84% match

Biomarkers in Drug Development: Statistical Methods and Applications (Chapman & Hall/CRC Biostatistics Series)

Chapman and Hall/CRC

£103.99 14 Nov 2026
Statistical Methods for Drug Safety (Chapman & Hall/CRC Biostatistics Series)
83% match

Statistical Methods for Drug Safety (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£103.05 15 Sep 2026
Biosimilars: Design and Analysis of Follow-on Biologics: 60 (Chapman & Hall/CRC Biostatistics)
83% match

Biosimilars: Design and Analysis of Follow-on Biologics: 60 (Chapman & Hall/CRC Biostatistics)

CRC Press

£150.16 29 Oct 2026
The Perception and Management of Drug Safety Risks (Health Systems Research)
82% match

The Perception and Management of Drug Safety Risks (Health Systems Research)

Springer

£78.01 15 Sep 2026
Translational Medicine: Strategies and Statistical Methods (Chapman & Hall/Crc Biostatistics, 28)
82% match

Translational Medicine: Strategies and Statistical Methods (Chapman & Hall/Crc Biostatistics, 28)

CRC Press

£65.73 27 Oct 2026
Dose Finding in Drug Development (Statistics for Biology and Health)
81% match

Dose Finding in Drug Development (Statistics for Biology and Health)

Springer

£109.98 26 Oct 2026
The Clinical Audit in Pharmaceutical Development: 104 (Drugs and the Pharmaceutical Sciences)
81% match

The Clinical Audit in Pharmaceutical Development: 104 (Drugs and the Pharmaceutical Sciences)

CRC Press

£95.77 22 Oct 2026
Biopharmaceutics and Pharmacokinetics Considerations (Advances in Pharmaceutical Product Development and Research)
80% match

Biopharmaceutics and Pharmacokinetics Considerations (Advances in Pharmaceutical Product Development and Research)

Elsevier

£132.44 03 Nov 2026
Statistical Methods in Drug Combination Studies: 69 (Chapman & Hall/CRC Biostatistics Series)
80% match

Statistical Methods in Drug Combination Studies: 69 (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£50.99 23 Oct 2026
Data and Safety Monitoring Committees in Clinical Trials (Chapman & Hall/CRC Biostatistics Series)
80% match

Data and Safety Monitoring Committees in Clinical Trials (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£100.51 16 Nov 2026
Biosimilars: Regulatory, Clinical, and Biopharmaceutical Development: 34 (AAPS Advances in the Pharmaceutical Sciences Series, 34)
80% match

Biosimilars: Regulatory, Clinical, and Biopharmaceutical Development: 34 (AAPS Advances in the Pharmaceutical Sciences Series, 34)

Springer

£124.31 23 Oct 2026
Handbook of Regression and Modeling: Applications for the Clinical and Pharmaceutical Industries (Chapman & Hall/CRC Biostatistics Series)
80% match

Handbook of Regression and Modeling: Applications for the Clinical and Pharmaceutical Industries (Chapman & Hall/CRC Biostatistics Series)

Chapman and Hall/CRC

£48.99 14 Sep 2026
Pharmacokinetics in Drug Development: Clinical Study Design and Analysis (Volume 1)
80% match

Pharmacokinetics in Drug Development: Clinical Study Design and Analysis (Volume 1)

Springer

£166.72 24 Oct 2026
Bioequivalence and Statistics in Clinical Pharmacology
79% match

Bioequivalence and Statistics in Clinical Pharmacology

Chapman and Hall/CRC

£145.99 01 Oct 2026
Generic Drug Product Development: Specialty Dosage Forms (Drugs and the Pharmaceutical Sciences)
79% match

Generic Drug Product Development: Specialty Dosage Forms (Drugs and the Pharmaceutical Sciences)

CRC Press

£65.73 15 Sep 2026
Dose Finding and Beyond in Biopharmaceutical Development (ICSA Book Series in Statistics)
79% match

Dose Finding and Beyond in Biopharmaceutical Development (ICSA Book Series in Statistics)

Springer

£154.66 20 Oct 2026
Biomarker Methods in Drug Discovery and Development (Methods in Pharmacology and Toxicology)
79% match

Biomarker Methods in Drug Discovery and Development (Methods in Pharmacology and Toxicology)

Humana

£101.76 11 Sep 2026
The Challenge of CMC Regulatory Compliance for Biopharmaceuticals
79% match

The Challenge of CMC Regulatory Compliance for Biopharmaceuticals

Springer

£120.74 23 Oct 2026
Applied Pharmacometrics: 14 (AAPS Advances in the Pharmaceutical Sciences Series, 14)
79% match

Applied Pharmacometrics: 14 (AAPS Advances in the Pharmaceutical Sciences Series, 14)

Springer

£200.08 17 Nov 2026
Applied Pharmacometrics: 14 (AAPS Advances in the Pharmaceutical Sciences Series, 14)
79% match

Applied Pharmacometrics: 14 (AAPS Advances in the Pharmaceutical Sciences Series, 14)

Springer

£109.00 17 Nov 2026
Approaching China's Pharmaceutical Market: A Fundamental Guide to Clinical Drug Development
79% match

Approaching China's Pharmaceutical Market: A Fundamental Guide to Clinical Drug Development

Springer

£113.73 23 Oct 2026
Quantitative Methods in Pharmaceutical Research and Development: Concepts and Applications
79% match

Quantitative Methods in Pharmaceutical Research and Development: Concepts and Applications

Springer

£93.36 24 Oct 2026
Discovering and Developing Molecules with Optimal Drug-Like Properties: 15 (AAPS Advances in the Pharmaceutical Sciences Series, 15)
79% match

Discovering and Developing Molecules with Optimal Drug-Like Properties: 15 (AAPS Advances in the Pharmaceutical Sciences Series, 15)

Springer

£147.31 17 Nov 2026